SCHEMBL1716892

SCHEMBL1716892

Cc1ccc(S(=O)(=O)OC[C@@H]2CC[C@](C)(C(C)(C)C)N(C(=O)O)C2)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.36
CYP2D6 P10635 4/20 0.36
CYP1A2 P05177 1/20 0.36
ALDH1A1 P00352 6/20 0.34
CYP2C9 P11712 3/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
MAPK1 P28482 2/20 0.34
HPGD P15428 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
CYP3A4 P08684 4/20 0.33
CYP2C19 P33261 3/20 0.33
TSHR P16473 2/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
SIRT5 Q9NXA8 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21987513 0.77 STAT3 (0.41) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9
SCHEMBL21987509 0.77 STAT3 (0.41) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9
SCHEMBL29156298 0.76 ALDH1A1 (0.40) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9
SCHEMBL29156227 0.76 ALDH1A1 (0.40) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9
SCHEMBL29156224 0.76 ALDH1A1 (0.40) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9
SCHEMBL13738496 0.76 ALDH1A1 (0.45) STAT3CYP2D6CYP1A2ALDH1A1KMT2A
SCHEMBL13740063 0.76 ALDH1A1 (0.45) STAT3CYP2D6CYP1A2ALDH1A1KMT2A
SCHEMBL7000711 0.76 ALDH1A1 (0.45) STAT3CYP2D6CYP1A2ALDH1A1KMT2A
SCHEMBL23705651 0.75 STAT3 (0.44) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9
SCHEMBL25307250 0.75 CYP2D6 (0.40) STAT3CYP2D6CYP1A2ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152690-B1 PYRIDYL PIPERIDINE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2012-01-11 EP disclosed
US-20110165632-A1 Process for the Preparation of an Orexin Receptor Antagonist MERCK SHARP & DOHME LLC 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165632-A1 Process for the Preparation of an Orexin Receptor Antagonist HCRTR2, HCRTR1, OXTR STAT3 4546/4885CYP2D6 2372/4885CYP1A2 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.